Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
7
7 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- KLU156Phase 34 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria
- KAE609CipargaminPhase 25 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria, Severe Malaria
- INE963Phase 23 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria
- BNT165cPhase 21 trial
BioNTech SE · Malaria
- BNT165dPhase 21 trial
BioNTech SE · Malaria
- GSK3772701Phase 21 trial
GSK · Malaria, Falciparum
- M5717Phase 21 trial
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.